Date published: 2026-3-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

PRDM4 Inhibitors

The chemical class known as PRDM4 Inhibitors encompasses a range of compounds that can inhibit the activity of PRDM4, a protein involved in chromatin remodeling and gene regulation. These inhibitors target various aspects of the pathways and processes in which PRDM4 is involved, employing different methods to exert their influence. One common approach is the inhibition of DNA methyltransferases. This method involves chemicals that can interfere with the addition of methyl groups to DNA, a process crucial for regulating gene expression. By altering the methylation landscape, these inhibitors can affect the activity of PRDM4, which is implicated in the regulation of gene expression through chromatin modification. Another strategy involves the use of histone deacetylase (HDAC) inhibitors. These compounds can alter the acetylation status of histones, thereby impacting chromatin structure and gene expression. Since PRDM4 is involved in chromatin-mediated gene regulation, modifying the histone acetylation can influence its activity.

In addition to these, there are inhibitors targeting the BET bromodomain, which disrupts protein-protein interactions crucial for the function of PRDM4 in gene regulation. By inhibiting these interactions, these compounds can affect the ability of PRDM4 to regulate gene expression. Furthermore, inhibitors of EZH1/2, enzymes involved in histone methylation, are also considered as part of this chemical class. These inhibitors can alter histone methylation patterns, thus influencing the regulatory role of PRDM4 in gene expression. The diversity of these compounds highlights the multifaceted nature of PRDM4's involvement in chromatin dynamics and gene regulation. By targeting different enzymes and processes in these pathways, these inhibitors can modulate the activity of PRDM4, demonstrating the complex interplay between various epigenetic mechanisms and gene regulation. The development and study of PRDM4 inhibitors represent a significant step in understanding the intricate networks of chromatin remodeling and gene expression regulation. These compounds provide valuable tools for research, allowing for the exploration of the roles and mechanisms of PRDM4 in various biological processes. Through their diverse modes of action, PRDM4 inhibitors offer insights into the complex regulation of gene expression and the modulation of chromatin architecture.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor that could possibly inhibit PRDM4 by altering gene expression patterns and chromatin remodeling.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

A histone deacetylase (HDAC) inhibitor, could possibly inhibit PRDM4 by affecting histone modification and gene regulation.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

An HDAC inhibitor, could possibly inhibit PRDM4 by altering chromatin structure and impacting gene expression regulation.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Similar to 5-Azacytidine, this DNA methylation inhibitor could possibly inhibit PRDM4 by influencing chromatin architecture and gene expression.

Panobinostat

404950-80-7sc-208148
10 mg
$200.00
9
(1)

A broad-spectrum HDAC inhibitor, could possibly inhibit PRDM4 by affecting histone modifications and gene expression related to its activity.

Romidepsin

128517-07-7sc-364603
sc-364603A
1 mg
5 mg
$218.00
$634.00
1
(1)

An HDAC inhibitor that can change chromatin structure, could possibly inhibit PRDM4 by influencing its role in gene expression.